Mounjaro Dosage: The Highest Dose, the Titration Schedule and How to Take It

The maximum Mounjaro dose is 15 mg once weekly in adults.1 For pediatric patients 10 years and older, the label caps the dose at 10 mg once weekly.1

No FDA-approved tirzepatide product goes above 15 mg a week. Zepbound, the weight-management brand of tirzepatide, also tops out at 15 mg once weekly.2 Our Zepbound dosage guide covers that schedule.

Mounjaro comes in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg.1 Each strength is made as a single-dose pen, a single-dose vial, a multi-dose vial and a single-patient-use KwikPen.1

Source: Mounjaro label, section 3.1 A multi-dose vial delivers each dose in 0.6 mL.1

The starting dose of Mounjaro is 2.5 mg injected under the skin once a week.1 It is also the lowest dose made. The label tells prescribers to follow the starting dose and escalation schedule to reduce the risk of stomach side effects.1

After at least 4 weeks on a dose, the prescriber can raise Mounjaro by 2.5 mg if more blood-sugar control is needed.1 The schedule does not require every patient to climb to 15 mg.1

At the fastest pace the label allows, the steps look like this:1

Tirzepatide reaches steady blood levels after 4 weeks of once-weekly dosing, which matches the 4-week step.1

For Mounjaro, the label ties dose increases to blood-sugar control, not to weight loss: a step up is considered after at least 4 weeks on the current dose if more glycemic control is needed.1 Mounjaro has no weight-loss dosing instructions because it is not approved for weight loss.1 Zepbound, the tirzepatide brand approved for weight reduction, uses the same 2.5 mg steps every 4 weeks.2

No, not under the label: each dose step requires at least 4 weeks on the current dose.1 Moving faster raises the risk of the stomach side effects the slow schedule is meant to limit.1

Mounjaro is not approved for weight loss, but in its diabetes trials weight fell more on higher doses: −6.3 kg on 5 mg, −7.0 kg on 10 mg and −7.8 kg on 15 mg at 40 weeks, against −1.0 kg on placebo.1 Those figures come from SURPASS-1, a 40-week trial of Mounjaro alone in adults with type 2 diabetes.1

In adults with obesity and no diabetes, tirzepatide sold as Zepbound produced larger losses. In the SURMOUNT-1 trial, average weight fell 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg after 72 weeks, against 3.1% on placebo.3,2 Higher doses also brought more stomach side effects, which is why the label leaves the maintenance dose to the prescriber.1

If weight management is the goal, our comparison of Mounjaro vs Zepbound explains why the two brands are prescribed differently, and our guide to Zepbound weight loss results breaks the trial numbers down by dose and timepoint.

Mounjaro is injected under the skin once a week, on the same schedule, at any time of day, with or without meals.1 The label lists three injection areas: the abdomen, the thigh, or the back of the upper arm when another person gives the shot.1 Rotate the injection site with each dose.1

The steps depend on the presentation. A single-dose pen is placed flat on the skin, unlocked and pressed for up to 10 seconds until the second click.5 A KwikPen needs a new pen needle and priming before each weekly dose.4 Our step-by-step guide on how to inject Mounjaro covers each one.

Once a week.1 Tirzepatide has a half-life of about 5 days, which is what allows once-weekly dosing.1

There is no best time of day on the label: Mounjaro can be taken at any time of day, with or without meals.1 What matters is keeping the weekly schedule. Our guide to the best time to take a GLP-1 covers how people pick a day and time.

Take the missed dose as soon as possible within 4 days (96 hours); if more than 4 days have passed, skip it and take the next dose on your usual day.1 In either case, go back to your regular weekly schedule afterward.1 Our missed dose tool works out the timing.

You can change your injection day if needed, as long as the two doses are at least 3 days (72 hours) apart.1

Tirzepatide reaches steady levels in the blood after 4 weeks of weekly dosing, but the label measures its full effect on blood sugar at 40 weeks.1 In SURPASS-1, HbA1c fell by 1.7 to 1.8 points across the three doses by week 40.1 For a week-by-week view of the weight-management brand, see how long Zepbound takes to work.

The label does not describe splitting Mounjaro doses, and the KwikPen is built to deliver only fixed doses.4 The KwikPen instructions say to turn the dose knob all the way until it stops for each weekly dose, and not to count clicks.4 After 4 doses, the pen is thrown away, including leftover medicine, which should not be injected or moved into a syringe.4

What's the lowest dose of Mounjaro? 2.5 mg once weekly, the starting dose.1

Can you get a fifth dose out of a Mounjaro KwikPen? No. The KwikPen holds 4 fixed doses and prevents dialing a full dose after 4 weekly injections. Lilly's instructions say not to inject the leftover medicine.4

How long do you have to take Mounjaro? The label sets no end date. Mounjaro is approved as an ongoing, once-weekly treatment alongside diet and exercise for type 2 diabetes.1 Decisions about stopping belong with your prescriber.

Do Mounjaro dose increases affect birth control pills? Yes. The label advises people using oral contraceptives to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase.1

Is the highest dose of tirzepatide the same for Mounjaro and Zepbound? Yes. Both labels set the adult maximum at 15 mg once weekly.1,2

Price changes with the brand, not with the dose. Our Mounjaro cost guide shows what Mounjaro costs with and without insurance, and the Zepbound cost guide does the same for the weight-management brand; if weight loss is the goal, our lowest-priced ways to get Zepbound are ranked separately. To compare prescribing options, see how to get tirzepatide online or browse our best GLP-1 options. Before your first dose, read about Mounjaro side effects.

This article is for information only and is not medical advice. Never change your Mounjaro dose without your prescriber. Mounjaro is a prescription drug with real risks and side effects, including a boxed warning for thyroid C-cell tumors.